1075727-02-4 Usage
General Description
"(1R-trans)-1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-2-tert-butoxycarbonylethyl-isoquinolinium besylate" is a chemical compound with a complex molecular structure. It belongs to the class of isoquinolinium derivatives and is commonly used as a pharmaceutical agent. (1R-trans)-1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-2-tert-butoxycarbonylethyl-isoquinolinium besylate exhibits potential pharmacological effects due to its structural features and has been studied for its potential therapeutic applications. Its besylate salt form enhances its solubility and stability, making it suitable for pharmaceutical formulations. This chemical has been investigated for its potential use in the treatment of certain medical conditions, and its unique molecular structure makes it a promising candidate for further research and development in the field of drug discovery.
Check Digit Verification of cas no
The CAS Registry Mumber 1075727-02-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,7,5,7,2 and 7 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1075727-02:
(9*1)+(8*0)+(7*7)+(6*5)+(5*7)+(4*2)+(3*7)+(2*0)+(1*2)=154
154 % 10 = 4
So 1075727-02-4 is a valid CAS Registry Number.
1075727-02-4Relevant articles and documents
CISATRACURIUM DERIVATIVES, PREPARATION AND USES THEREOF
-
Page/Page column 18; 19, (2009/12/05)
The present invention provides compounds which are useful, e.g., as reference markers for analyzing the purity of cisatracurium and salts thereof, a test method for determining the said purity and processes for preparing reference markers.
PROCESS FOR PRODUCING CISATRACURIUM COMPOUNDS AND ASSOCIATED INTERMEDIATES
-
Page/Page column 34-36, (2008/12/08)
The present invention provides processes for producing isoquinolinium compounds, and for converting them into cisatracurium salts, e.g., cisatracurium besylate
